Press release
Strong Growth Ahead: Dengue Treatment Market Size To Grow At Arecord 11.6% Cagr By 2029
Dengue Treatment Market Size
How Big Is the Dengue Treatment Market Size Expected to Be by 2034?
The market for dengue treatment has experienced rapid expansion in the last few years. The market size is expected to scale up from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The growth seen in previous years can be credited to advancements in diagnostic tools, contributions from government and non-governmental organizations, the implementation of epidemiological surveillance systems, considerable r&d investments, and initiatives aimed at community education.
The market size for dengue treatment is forecasted to witness a swift expansion in the upcoming years. It is projected to reach $3.64 billion by 2029 with a compound annual growth rate (CAGR) of 11.6%. The predicted growth during the forecast period can be ascribed to factors like the creation of universal vaccines, broader vaccine access, collaborations between public and private sectors, progress in telemedicine, and improvements in policy framework. Key trends expected during the forecast period involve next-generation dengue vaccines, AI-enabled drug discovery, smart tools for contact tracing, 3D-printed vaccines, and crispr for targeting the virus.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745
What Are the Emerging Segments Within the Dengue Treatment Market?
The dengue treatment market covered in this report is segmented -
1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
What Long-Term Drivers Are Shaping Dengue Treatment Market Trends?
Anticipated growth in the dengue treatment market is forecasted to stem from the escalating rate of dengue fever occurrences. Dengue is a viral infection transmitted by mosquitoes, resulting in symptoms akin to the flu, potentially leading to severe complications if untreated. The uptick in dengue cases can be linked chiefly to increased urbanization, climate alterations conducive to mosquito breeding, lack of efficient vector control strategies, and the expansion of the population in areas with a high risk of infection. Dengue treatments contribute to the reduction of dengue incidents through prompt medical response, mitigating the severity of symptoms, averting complications, and suppressing the spread of the disease through enhanced patient outcomes and the propagation of public health consciousness. For instance, a study released by the Centers for Disease Control and Prevention, a government agency based in the US, revealed a surge in dengue fever cases in the Americas to over 4.6 million with about 4,000 casualties in 2023. This marked a 13% increase compared to the same period in the previous year and a considerable escalation from earlier years. Therefore, this surge in dengue cases acts as a catalyst driving the growth of the dengue treatment market.
Who Are the Top Competitors in Key Dengue Treatment Market Segments?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healare Limited, Biological E. Limited
What Actigraphy Devices Market Trends Are Gaining Traction Across Different Segments?
Leading players in the dengue treatment market are endeavoring to develop solutions like broad-spectrum antiviral medicines that aim to augment treatment potency, decrease the intensity of the disease, and simultaneously tackle multiple dengue virus serotypes. Broad-spectrum antiviral medication is understood to be a compound that is potent against a variety of viruses, instead of focusing on a single specific virus. For example, Hyundai Pharmaceutical Co. Ltd., a pharmaceutical product manufacturer based in South Korea, introduced XAFTY in September 2024. This revolutionary broad-spectrum antiviral aims to manage several viral infections, including COVID-19 and dengue fever. Its distinct characteristics include an inventive drug that escalates the absorption and efficacy of niclosamide, established safety, and proven effectiveness coming from clinical trials, the capacity to target an array of RNA viruses, giving it flexibility against prospective future threats, and the potential for swift reaction, allowing for speedy supply to regions dealing with public health emergencies.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
Which Regions Are Becoming Hubs for Dengue Treatment Market Innovation?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Dengue Treatment Market?
2. What is the CAGR expected in the Dengue Treatment Market?
3. What Are the Key Innovations Transforming the Dengue Treatment Industry?
4. Which Region Is Leading the Dengue Treatment Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strong Growth Ahead: Dengue Treatment Market Size To Grow At Arecord 11.6% Cagr By 2029 here
News-ID: 4067678 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
